Epsilogen
Series BLondon, UKMar 2022
Epsilogen raised €37M in a Series B round in Mar 2022. The company is based in London, UK. Investors in the round: 3B Future Health Fund, British Patient Capital, Caribou Property Limited and 2 others. Data as of Nov 2026.
Amount raised
€37M
€36,907,677
Native amount
30,750,000 GBP
Stage
Series B
series b
Investors
5
Provenance & confidence
High confidenceAmount
30,750,000 GBP
ECB-at-date → €37M · rate 0.83316 on 2022-03-02
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 named3B Future Health FundBritish Patient CapitalCaribou Property LimitedNovartis Venture FundSchroders Capital
Date
Mar 2022
Round type
series b
Amount (EUR)
€37M
Other rounds
same companyThis is the company's only recorded round.